These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 390054)
1. Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. Kauffmann RH; Van Es LA; Daha MR J Immunol Methods; 1979; 31(1-2):11-22. PubMed ID: 390054 [TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566 [TBL] [Abstract][Full Text] [Related]
3. Detection of immune complexes by their complement-dependent binding to bovine conglutinin: technical aspects of a solid-phase immunoenzyme microassay and its application to normal and pathological sera. Raffin T; Bringuier JP; Veysseyre CM; Trepo C; Lamelin JP J Immunol Methods; 1983 Mar; 58(1-2):155-70. PubMed ID: 6403624 [TBL] [Abstract][Full Text] [Related]
4. Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system. Farrell C; Sogaard H; Svehag SE Scand J Immunol; 1975; 4(7):673-80. PubMed ID: 1198069 [TBL] [Abstract][Full Text] [Related]
5. Calcium-dependent and calcium-independent signals in the conglutinin-binding assay (KgBa) for immune complexes. Influence of anti-collagen-antibodies. Holmskov U; Haas H; Teisner B; Andersen O; Jensenius JC J Immunol Methods; 1992 Apr; 148(1-2):225-32. PubMed ID: 1564328 [TBL] [Abstract][Full Text] [Related]
6. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features. Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561 [TBL] [Abstract][Full Text] [Related]
7. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule. Svehag SE Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070 [TBL] [Abstract][Full Text] [Related]
8. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. Doekes G; Vanes LA; Daha MR Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172 [TBL] [Abstract][Full Text] [Related]
9. Binding and activation of the first complement component by soluble immune complexes: effect of complex size and composition. Doekes G; van Es LA; Daha MR Scand J Immunol; 1984 Feb; 19(2):99-110. PubMed ID: 6701474 [TBL] [Abstract][Full Text] [Related]
10. An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q binding. Spaeth PJ; Corvetta A; Nydegger UE; Montroni M; Buetler R Scand J Immunol; 1983 Oct; 18(4):319-28. PubMed ID: 6606219 [TBL] [Abstract][Full Text] [Related]
11. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929 [TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. Nydegger UE; Lambert PH; Gerber H; Miescher PA J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246 [TBL] [Abstract][Full Text] [Related]
13. Detection and differentiation of immune complexes and IgG aggregates by a complement consumption assay. Nielsen H; Svehag SR Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):261-9. PubMed ID: 961436 [TBL] [Abstract][Full Text] [Related]
14. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients. Krieger G; Bause I; Kneba M; Kehl A; Nagel GA J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419 [TBL] [Abstract][Full Text] [Related]
15. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. Rossen RD; Reisberg MA; Hersh EM; Gutterman JU J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505 [TBL] [Abstract][Full Text] [Related]
17. The detection of circulating immune complexes containing immunoglobulin G. Valentijn RM; van Es LA; Westedt ML; Daha MR J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049 [TBL] [Abstract][Full Text] [Related]
18. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA. Larsson A; Sjöquist J J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142 [TBL] [Abstract][Full Text] [Related]
19. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system. Antes U; Heinz HP; Loos M J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573 [TBL] [Abstract][Full Text] [Related]
20. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes. Kilgallon W; Amlot PL; Williams BD Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]